• Explore /
  • Poster
  • / Enfortumab vedotin plus pembrolizumab in the treatment of locally advanced or metastatic bladder cancer of variant histology: A phase II study.

Enfortumab vedotin plus pembrolizumab in the treatment of locally advanced or metastatic bladder cancer of variant histology: A phase II study.

Abstract Poster

Authors

Bassel Nazha

Bassel Nazha

Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA

Bassel Nazha , Jacqueline T Brown , Yuan Liu , Haydn Kissick , Bradley Curtis Carthon , Omer Kucuk , Lara R Harik , Vikram M Narayan , Shreyas S Joshi , Mehmet Asim Bilen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Urothelial Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT05756569

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr TPS4615)

DOI

10.1200/JCO.2024.42.16_suppl.TPS4615

Abstract #

TPS4615

Poster Bd #

306a

Abstract Disclosures

Similar Posters

First Author: Nikhil Pramod

First Author: Haojie Li

First Author: Christopher J. Hoimes

First Author: Nikhil Pramod